IQVIA and Veeva Systems announced a comprehensive strategic partnership on August 18, 2025, establishing global clinical and commercial collaborations while resolving all pending legal disputes between the two life sciences technology leaders. The long-term agreement enables customers to seamlessly integrate software, data, technology, and service offerings from both companies.
Commercial Integration Capabilities
The partnership establishes master data and software third-party access (TPA) agreements that allow IQVIA or Veeva data to be used with each other's software or services in customer instances. This includes the integration of IQVIA data in Veeva Network for master data management (MDM), Veeva Nitro for analytics, and Veeva AI platforms.
IQVIA has joined the Veeva Technology, AI, and Services Partner Programs to support customer integrations between Veeva software and IQVIA's commercial offerings, including IQVIA Analytics, IQVIA Information Management, IQVIA Agentic AI, and IQVIA Commercial Orchestration. The partnership also streamlines the process for customers to obtain TPAs for projects through fast, easy procedures.
Clinical Trial Acceleration
Under the clinical partnership, IQVIA has joined Veeva's CRO Clinical Data Partner program and can leverage the Veeva Clinical Suite to execute clinical trials using Veeva software products, including study builds with Veeva EDC. This collaboration combines IQVIA's clinical data management, clinical technology solutions, and EDC programming expertise with Veeva software to accelerate database builds, study locks, and data delivery.
Industry Impact and Leadership Perspectives
"We are committed to supporting frictionless product and services integration with IQVIA for the benefit of our joint customers and the industry overall," said Peter Gassner, Veeva founder and CEO. "I am excited about the potential for our clinical and commercial partnerships to create significant value for our shared customers."
Ari Bousbib, chairman and CEO of IQVIA, emphasized the strategic value of the collaboration: "IQVIA and Veeva's partnerships bring together best-in-class capabilities in information, AI, technology, and services for our shared clients. This will enable IQVIA customers on Veeva platforms to accelerate clinical development, bring treatments to market more efficiently, and improve access to innovations for patients."
Company Profiles and Market Position
IQVIA operates as a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. The company employs approximately 89,000 people across over 100 countries and serves biotech, medical device and pharmaceutical companies, medical researchers, government agencies, and payers.
Veeva Systems serves as the global leader in cloud software for the life sciences industry, supporting more than 1,000 customers ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva balances the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves.
